Procalcitonin Dynamics After Long-Term Ventricular Assist Device Implantation

Area of Science:

• Cardiology
• Infectious Diseases
• Biomarkers

Background:

• Infectious complications (IC) are a major cause of poor outcomes after long-term ventricular assist device (LVAD) implantation.
• Procalcitonin (PCT) is a commonly used biomarker for diagnosing bacterial infections.

Purpose of the Study:

• To evaluate the dynamic changes in PCT levels following LVAD surgery.
• To determine the relationship between PCT levels and the occurrence of infectious complications post-LVAD.

Main Methods:

• Prospective assessment of PCT levels in 25 patients undergoing LVAD implantation.
• PCT measurements were taken pre-surgery and on postoperative days 1, 2, 14, and 30.
• PCT values were compared between patients with and without infectious complications.

Main Results:

• PCT levels rose post-LVAD surgery and returned to baseline by days 14 and 30.
• No significant difference in PCT was observed between patients with or without IC or right ventricle assist device (RVAD).
• Acute renal failure (ARF) and/or RVAD use were associated with significantly higher PCT levels on postoperative days 2, 14, and 30.

Conclusions:

• The diagnostic utility of PCT for detecting infectious complications after LVAD implantation is limited.
• PCT concentrations post-LVAD surgery may better reflect general postoperative complications rather than specific infections.